For pharmacy technicians, understanding diabetes pharmacological management is particularly important. Pharmacy technicians are involved in medication dispensing, preparation, stock management, medication-related communication, and, within their scope of practice, supporting patients and pharmacists in the safe use of diabetes medicines.

Diabetes is one of the most significant chronic diseases affecting populations worldwide. The number of people living with diabetes increased from approximately 200 million in 1990 to 830 million in 2022, with prevalence increasing more rapidly in low- and middle-income countries. More than half of adults living with diabetes were not taking medication for the condition in 2022.

Diabetes can be managed, and many of its complications can be prevented or delayed through appropriate nutrition, physical activity, medication, regular monitoring, and screening for complications.

This guide provides an overview of diabetes, its major types, symptoms, diagnosis, complications, and the medicines commonly used in its management.

What Is Diabetes Mellitus?

Diabetes mellitus is a chronic metabolic disease characterized by elevated blood glucose levels.

It develops when the pancreas does not produce enough insulin, when the body cannot effectively use the insulin it produces, or through other mechanisms depending on the type of diabetes.

Insulin is a hormone produced by pancreatic beta cells. It helps regulate blood glucose by facilitating glucose uptake and utilization in tissues and by suppressing excessive hepatic glucose production.

When insulin production or action is inadequate, blood glucose rises. Persistent hyperglycemia can eventually damage blood vessels, nerves, the kidneys, eyes, and other organs.

Understanding these mechanisms helps pharmacy professionals understand why different diabetes medicines work through different pathways.

Types of Diabetes

Diabetes is not a single disease. Several forms exist, with different causes and treatment approaches.

Type 1 Diabetes

Type 1 diabetes is an autoimmune disease in which the immune system destroys pancreatic beta cells, resulting in little or no endogenous insulin production.

Because insulin deficiency is usually absolute, insulin replacement is essential for people with type 1 diabetes.

Type 2 Diabetes

Type 2 diabetes is the most common form of diabetes.

It involves varying degrees of insulin resistance, progressive impairment of pancreatic beta-cell function, and inadequate insulin secretion relative to the body's needs.

Risk is influenced by genetic, metabolic, environmental, and lifestyle factors.

Treatment may involve lifestyle interventions, glucose-lowering medicines, and eventually insulin when necessary.

Gestational Diabetes

Gestational diabetes is diabetes diagnosed during pregnancy that was not clearly present before pregnancy.

Pregnancy-related hormonal changes can increase insulin resistance and increase the body's demand for insulin.

People who develop gestational diabetes also have an increased future risk of developing type 2 diabetes.

Other Specific Types of Diabetes

Diabetes can also result from other conditions or causes, including pancreatic disease, pancreatic surgery, certain genetic disorders, and some medicines.

For example, diabetes associated with pancreatic disease is sometimes classified as type 3c diabetes, also known as pancreatogenic diabetes.

What About LADA?

Latent autoimmune diabetes in adults (LADA) is a form of adult-onset autoimmune diabetes that may initially resemble type 2 diabetes because insulin dependence may develop gradually.

The term “type 1.5 diabetes” is sometimes used informally to describe LADA, but it is not a standard formal diabetes classification.

Pathophysiology of Diabetes

The underlying mechanisms differ according to the type of diabetes.

Type 1 Diabetes

Autoimmune destruction of pancreatic beta cells results in severe insulin deficiency.

Without sufficient insulin, glucose cannot be adequately regulated, and the body may begin breaking down fat for energy. This can result in ketone production and, if untreated, diabetic ketoacidosis (DKA).

Type 2 Diabetes

Type 2 diabetes involves several abnormalities, including:

• Insulin resistance

• Progressive beta-cell dysfunction

• Increased hepatic glucose production

• Abnormal glucagon regulation

• Altered incretin activity

• Increased renal glucose reabsorption

Over time, insulin secretion may become insufficient to compensate for insulin resistance.

Diabetes Related to Pancreatic Disease

Damage to pancreatic tissue can impair insulin production.

Possible causes include:

• Chronic pancreatitis

• Pancreatic surgery

• Pancreatic cancer

• Cystic fibrosis

• Other pancreatic disorders

Symptoms of Diabetes

Common symptoms of diabetes include:

• Increased thirst

• Frequent urination

• Increased hunger

• Unexplained weight loss

• Fatigue

• Blurred vision

• Slow-healing wounds

• Recurrent infections

• Numbness or tingling in the hands or feet

However, some people with type 2 diabetes may have few or no obvious symptoms, particularly during the early stages.

This is one reason regular screening is important for people at increased risk.

Diagnosis of Diabetes

Several laboratory tests can be used to diagnose diabetes.

Fasting Plasma Glucose

The fasting plasma glucose test measures blood glucose after at least 8 hours without food.

For non-pregnant adults, a fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher is within the diagnostic range for diabetes.

HbA1c

The HbA1c test measures glycated hemoglobin and provides an estimate of average blood glucose over approximately the previous 2–3 months.

An HbA1c of 6.5% or higher is within the diagnostic range for diabetes in appropriate clinical circumstances.

Oral Glucose Tolerance Test

An oral glucose tolerance test measures the body's response to a standardized glucose load.

A 2-hour plasma glucose of 200 mg/dL (11.1 mmol/L) or higher is within the diagnostic range for diabetes.

Random Plasma Glucose

In a person with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose of 200 mg/dL (11.1 mmol/L) or higher is within the diagnostic range for diabetes.

The appropriate test and whether confirmation is required depend on the clinical circumstances.

Risk Factors for Diabetes

Risk factors vary according to the type of diabetes.

Non-Modifiable or Less-Modifiable Factors

These include:

• Family history

• Increasing age

• Genetic susceptibility

• Previous gestational diabetes

• History of certain metabolic conditions

• Certain ethnic or population backgrounds

Modifiable or Potentially Modifiable Factors

These may include:

• Excess body weight

• Physical inactivity

• Unhealthy dietary patterns

• Tobacco use

• Poor sleep

• Certain metabolic conditions

Not every person with diabetes has modifiable risk factors, and diabetes should not be viewed simply as a consequence of lifestyle choices.

Complications of Diabetes

Persistent hyperglycemia can contribute to serious complications.

Acute Complications

Hypoglycemia

Hypoglycemia occurs when blood glucose falls below the individual's appropriate range and can cause:

• Sweating

• Trembling

• Hunger

• Palpitations

• Confusion

• Dizziness

• Seizures

• Loss of consciousness

It is particularly important in people using insulin or medicines that increase insulin secretion.

Diabetic Ketoacidosis

DKA is a potentially life-threatening metabolic emergency characterized by hyperglycemia or, in some circumstances, less marked glucose elevation, ketosis, and metabolic acidosis.

It occurs most commonly in type 1 diabetes but can also occur in people with type 2 diabetes under certain circumstances.

Hyperosmolar Hyperglycemic State

HHS is characterized by severe hyperglycemia, hyperosmolarity, and profound dehydration, usually with little or no significant ketoacidosis.

It is a medical emergency requiring urgent treatment.

Chronic Complications

Long-term diabetes can contribute to:

• Cardiovascular disease

• Chronic kidney disease

• Diabetic retinopathy

• Peripheral neuropathy

• Peripheral arterial disease

• Foot ulcers

• Lower-limb amputation

• Sexual dysfunction

• Gastroparesis

Diabetes is also associated with an increased risk of several other health problems.

Diabetes Pharmacological Management

Diabetes pharmacological management involves selecting and using medicines that improve glycemic control while considering the individual's overall health, treatment goals, adverse-effect risks, comorbidities, preferences, and access to treatment.

Treatment differs significantly between type 1 and type 2 diabetes.

Current diabetes guidelines emphasize a person-centered approach rather than assuming that one medicine is appropriate for everyone with type 2 diabetes. Treatment selection should consider factors such as cardiovascular disease, kidney disease, heart failure, body weight, hypoglycemia risk, adverse effects, cost, access, and patient preferences.

Diabetes Pharmacological Management (Type 1 Diabetes)

People with type 1 diabetes require insulin because the disease is characterized by severe or near-absolute insulin deficiency.

Modern insulin treatment generally involves a combination of:

• Basal insulin

• Prandial or mealtime insulin

• Correction doses when appropriate

Insulin may be delivered through multiple daily injections or an insulin pump.

Continuous glucose monitoring and automated insulin delivery systems can also form part of modern diabetes management for appropriate patients.

Insulin Preparations

Insulins can be broadly classified according to their pharmacokinetic profiles.

The exact onset, peak, and duration vary according to the specific product and formulation. Pharmacy professionals should therefore refer to the product information rather than relying on a single generalized duration.

Diabetes Pharmacological Management in Type 2 Diabetes

The choice of medication for type 2 diabetes should be individualized.

Although metformin remains an important and commonly used glucose-lowering medicine, current guidelines do not recommend treating it as an automatic first choice for every patient regardless of comorbidities.

For people with established or high-risk cardiovascular disease, heart failure, chronic kidney disease, or obesity, medications with demonstrated cardiovascular, kidney, or weight-related benefits may influence treatment selection independently of glucose-lowering needs.

1. Biguanides

Example: Metformin

Metformin reduces hepatic glucose production and improves insulin sensitivity.

Common adverse effects include:

• Nausea

• Diarrhea

• Abdominal discomfort

• Reduced appetite

Gastrointestinal adverse effects can often be reduced by gradual dose escalation and appropriate administration.

Lactic acidosis is rare but serious and is associated particularly with significant renal impairment and other high-risk conditions.

Internal link suggestion: Link “Metformin” to your previous article about metformin if available.

2. Sulfonylureas

Examples include:

• Glimepiride

• Gliclazide

• Glibenclamide

Sulfonylureas stimulate pancreatic beta cells to release insulin.

Important adverse effects include:

• Hypoglycemia

• Weight gain

The risk of hypoglycemia is particularly important in older adults and people with impaired kidney function.

3. DPP-4 Inhibitors

Examples include:

• Sitagliptin

• Linagliptin

• Vildagliptin

DPP-4 inhibitors increase the activity of endogenous incretin hormones, helping increase glucose-dependent insulin secretion and reduce glucagon secretion.

They generally have a relatively low risk of hypoglycemia when used without insulin or insulin secretagogues.

4. SGLT2 Inhibitors

Examples include:

• Empagliflozin

• Dapagliflozin

• Canagliflozin

SGLT2 inhibitors reduce renal glucose reabsorption, increasing urinary glucose excretion.

Depending on the specific medicine and patient characteristics, this class can provide important cardiovascular and kidney benefits in addition to glucose lowering.

Potential adverse effects include:

• Genital mycotic infections

• Volume depletion

• Increased urination

• Rare but serious diabetic ketoacidosis

Pharmacy professionals should be particularly alert to sick-day considerations and symptoms suggestive of DKA.

5. GLP-1 Receptor Agonists

Examples include:

• Semaglutide

• Liraglutide

• Dulaglutide

GLP-1 receptor agonists enhance glucose-dependent insulin secretion, reduce glucagon secretion, slow gastric emptying to varying degrees, and promote satiety.

They can produce substantial glucose lowering and weight reduction, with some agents demonstrating cardiovascular benefits.

Common adverse effects include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

6. Dual GIP/GLP-1 Receptor Agonist

Example: Tirzepatide

Tirzepatide activates both GIP and GLP-1 receptors.

It provides substantial glucose-lowering and weight-management effects and is increasingly important in modern diabetes pharmacotherapy.

Its use should be individualized according to approved indications, patient factors, tolerability, and local treatment guidelines.

7. Thiazolidinediones

Example: Pioglitazone

Pioglitazone improves insulin sensitivity through activation of PPAR-γ.

Potential adverse effects include:

• Weight gain

• Fluid retention

• Edema

• Increased risk of heart failure in susceptible patients

It therefore requires careful patient selection.

8. Alpha-Glucosidase Inhibitors

Example: Acarbose

Acarbose delays carbohydrate digestion and absorption in the intestine, reducing postprandial glucose excursions.

Common adverse effects include:

• Flatulence

• Abdominal discomfort

• Diarrhea

Summary of Major Glucose-Lowering Medicines

The choice of medicine should be individualized rather than based solely on drug class. Current ADA guidance emphasizes cardiovascular, kidney, weight, hypoglycemia, tolerability, cost/access, and patient-preference considerations.

Recent Advances in Diabetes Pharmacotherapy

Diabetes treatment continues to evolve.

GLP-1-Based Therapies

GLP-1 receptor agonists have become increasingly important because of their glucose-lowering, weight-management, and, for selected agents, cardiovascular benefits.

Dual GIP/GLP-1 Therapy

Dual GIP/GLP-1 receptor agonism has introduced another therapeutic approach for people with type 2 diabetes and related metabolic conditions.

Continuous Glucose Monitoring

Continuous glucose monitoring (CGM) provides information about glucose levels and trends and can improve glycemic management in appropriate patients.

Automated Insulin Delivery

Automated insulin delivery systems combine glucose monitoring with insulin delivery algorithms to adjust insulin administration.

The ADA's 2026 recommendations support appropriate use of continuous glucose monitoring and automated insulin delivery systems in people who may benefit from them.

Non-Pharmacological Management of Diabetes

Medicines are only one component of diabetes care.

Non-pharmacological management may include:

• Healthy dietary patterns

• Regular physical activity

• Weight management when appropriate

• Diabetes self-management education and support

• Smoking cessation

• Appropriate alcohol use

• Regular blood glucose monitoring when indicated

• Adequate sleep

• Regular screening for diabetes complications

Lifestyle measures should complement, rather than unnecessarily replace, appropriate pharmacological treatment.

Role of Pharmacy Technicians in Diabetes Management

Pharmacy technicians can contribute significantly to diabetes care within their training, legal scope of practice, and workplace responsibilities.

Their roles may include:

Medication Dispensing and Preparation

Pharmacy technicians help ensure that diabetes medicines are correctly selected, labeled, packaged, and supplied according to established procedures.

Medication Adherence Support

Technicians may identify practical barriers such as:

• Complex medication schedules

• Missed doses

• Difficulty obtaining medicines

• Confusion about administration

• Problems with medication supplies

Concerns requiring clinical assessment should be referred to the pharmacist or appropriate healthcare professional.

Patient Education Within Scope

Depending on the healthcare setting and scope of practice, pharmacy technicians can reinforce established instructions concerning:

• Medicine administration

• Storage

• Device handling

• Prescription directions

• Blood glucose-monitoring supplies

They should refer clinical questions, medication changes, adverse reactions, and individualized treatment decisions to the pharmacist or other qualified healthcare professional.

Medication Safety

Pharmacy technicians can help identify:

• Duplicate medicines

• Incorrect strengths

• Missing prescriptions

• Potential dispensing errors

• Insulin product or concentration discrepancies

Insulin errors can be particularly dangerous, making accurate dispensing and labeling essential.

Community Health Education

Pharmacy technicians can support diabetes-awareness activities by promoting appropriate screening, healthy lifestyle practices, medication adherence, and referral to healthcare professionals.

Key Takeaways

Diabetes is a complex chronic disease requiring individualized management.

The major principles to remember are:

1. Type 1 diabetes requires insulin replacement.

2. Type 2 diabetes may require lifestyle intervention, glucose-lowering medicines, and sometimes insulin.

3. Diabetes pharmacological management should be individualized according to the patient's clinical circumstances.

4. Metformin remains an important treatment option, but it is not automatically the best first choice for every person with type 2 diabetes.

5. SGLT2 inhibitors and GLP-1-based therapies have important cardiovascular, kidney, and weight-related roles for selected patients.

6. Sulfonylureas and insulin can cause hypoglycemia and require appropriate monitoring.

7. Diabetes medicines should be selected with consideration of adverse effects, comorbidities, treatment goals, cost, access, and patient preferences.

8. Pharmacy technicians contribute to diabetes care through safe dispensing, medication support, education within scope, and identification of medication-safety problems.

Effective diabetes pharmacological management is therefore not simply about lowering blood glucose. It involves selecting appropriate therapy, supporting adherence, minimizing medication-related harm, and addressing the patient's broader cardiovascular, kidney, metabolic, and quality-of-life needs.

For pharmacy technicians, maintaining current knowledge of diabetes medicines is essential because diabetes pharmacotherapy continues to evolve rapidly.

Pharm Tech Important Link Bank:

Here are a few helpful resources to support your pharmacy technician career:

🔗 Free CEUs for Pharmacy Technicians
https://www.pharmtechsonly.com/resource-center/free-ceus/

🔗 Search Upcoming Conventions in Your Area
https://www.pharmtechsonly.com/resource-center/conventions/

🔗 Rx Study Buddy Kit (Top 200, Math, Law)
https://www.pharmtechsonly.com/store/

🔗 Search Pharmacy Technician Jobs
https://tc.pharmtechsonly.com/careers